SLC25A12

Chr 2AR

solute carrier family 25 member 12

Also known as: AGC1, ARALAR, DEE39, EIEE39

This gene encodes a calcium-binding mitochondrial carrier protein. The encoded protein localizes to the mitochondria and is involved in the exchange of aspartate for glutamate across the inner mitochondrial membrane. Polymorphisms in this gene may be associated with autism, and mutations in this gene may also be a cause of global cerebral hypomyelination. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Apr 2012]

OMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 0.421 OMIM phenotype
Clinical SummarySLC25A12
🧬
Gene-Disease Validity (ClinGen)
mitochondrial disease · ARModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.24) despite low pLI — interpret in context.
📋
ClinVar Variants
23 unique Pathogenic / Likely Pathogenic· 235 VUS of 566 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.42LOEUF
pLI 0.216
Z-score 4.34
OE 0.24 (0.140.42)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
2.71Z-score
OE missense 0.61 (0.540.68)
226 obs / 373.5 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.24 (0.140.42)
00.351.4
Missense OE?0.61 (0.540.68)
00.61.4
Synonymous OE?1.08
01.21.6
LoF obs/exp: 9 / 37.8Missense obs/exp: 226 / 373.5Syn Z: -0.72

This gene — mechanism propensity

DN
0.74top 25%
GOF
0.82top 10%
LOF
0.3164th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function, dominant-negative and loss-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median
LOF74% of P/LP variants are LoF · LOEUF 0.42

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

566 submitted variants in ClinVar

Classification Summary

Pathogenic13
Likely Pathogenic10
VUS235
Likely Benign263
Benign22
Conflicting8
13
Pathogenic
10
Likely Pathogenic
235
VUS
263
Likely Benign
22
Benign
8
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
9
2
2
0
13
Likely Pathogenic
8
2
0
0
10
VUS
3
209
20
3
235
Likely Benign
0
1
130
132
263
Benign
0
2
16
4
22
Conflicting
8
Total20216168139551

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

24 pathogenic / likely-pathogenic (of 30) ClinVar copy-number / structural variants overlap SLC25A12 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SLC25A12 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →